Although GRs regulate HPA axis via negative feedback in the CNS, changes in GRs on PBMCs have been reported in psychiatric diseases, including changes in the number and sensitivity of GRs (68, 69) and GR promoter methylation status and mRNA expression (67, 70–72). The gene discussed is BCL2A1; the disease is psychiatric disorder.